• 1000 liter Fermentor
    The Center for Biocatalysis and Bioprocessing offers a wide range of professional and research-based services such as gene cloning, clonal selection, fermentation, downstream purification, bioprocessing, and other various instrumental methods to serve local, national, and international clientele. With a large collection of state-of-the-art facilities & equipment, we are committed to delivering high-quality bioproducts, providing outstanding client experience, and promoting excellent biotech education.
  • CBB staff with column
    CBB's​ main laboratory concentrates on research and process development (RPD). The RPD laboratory is 13,000 Sq Ft and operates with the discipline of safe lab practices, standard operating procedures (SOPs), good documentation and well-defined protocols. The CBB RPD laboratory offers gene cloning, clonal selection, state-of-the-art fermentation, downstream purification, bioprocessing and analytical services. All work is performed by experienced, professional full-time staff with expertise in process development.
  • cGMP fermentor
    In addition to research and process development laboratory, CBB provides cGMP fermentation and protein purification services for Phase 1 clinical trials. cGMP laboratory started its operations in 2007. All the critical equipment in the cGMP facilities have been qualified with Factory Acceptance Tests (FAT), IQ and OQ. Since 2007, CBB has successfully executed more than 50 campaigns. This has resulted in IND filing by a client.
Biotech Services CBB offers a wide range of professional and research-based services such as gene cloning, clonal selection, fermentation, downstream purification, bioprocessing, and other various instrumental methods for local, national, and international clientele.
Biotech Training Program learn about the program, available fellowships and training grants
Research learn about our research
Annual CBB Conference featuring world renowned speakers, representatives and attendees from industry and academia
14
patents
on glycolate oxidase (GO) technology from E. I. DuPont de Nemours and Co.
$
3.57
million
UI portion of $18 million NSF ERC grant
8
Biologics
Produced for Phase I